Výsledky vyhledávání - "Under-dosing"

Akademický článek

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction

Autor: Hans D de Boer, Ricardo V Carlos, Sorin J Brull

Publikováno v: BMC Anesthesiology, Vol 18, Iss 1, Pp 1-5 (2018)

Abstract Background Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European medicines agency and today is used in clinical anesthesia and emergency me

Externí odkaz: https://doaj.org/article/e1448e3171ed4e198eef26ec64d5c589

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry

Publikováno v: Journal of neurology 269(1), 470-480 (2021). doi:10.1007/s00415-021-10866-2
Journal of Neurology

Aims We aimed to analyze prevalence and predictors of NOAC off-label under-dosing in AF patients before and after the index stroke. Methods The post hoc analysis included 1080 patients of the investigator-initiated, multicenter prospective Berlin Atr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c373254dc7a6e10e91fffd446eae0d
https://pub.dzne.de/record/162787

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction

Autor: Ricardo Vieira Carlos, Sorin J. Brull, Hans D. de Boer

Publikováno v: BMC Anesthesiology
BMC Anesthesiology, Vol 18, Iss 1, Pp 1-5 (2018)

Background Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European medicines agency and today is used in clinical anesthesia and emergency medicine gl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6501d53556ddc5f738121edcb7e1855
https://pubmed.ncbi.nlm.nih.gov/30400850

Zobrazit plný text záznamu

Plný text ve formátu HTML

Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient

Autor: Bruno Pradines, Nicolas Paleiron, Serge Védy, Fabrice Simon, Emilie Javelle, Jean Baptiste Roseau, Marylin Madamet

Publikováno v: Malaria Journal
Malaria Journal, BioMed Central, 2016, 15, ⟨10.1186/s12936-016-1535-8⟩
Malaria Journal, 2016, 15, ⟨10.1186/s12936-016-1535-8⟩

International audience; Background: Artemisinin-based combination therapy (ACT) introduced in the mid-1990s has been recommended since 2005 by the World Health Organization as first-line treatment against Plasmodium falciparum in all endemic countrie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad88cfe2fcee5a0dbfc9db0840d3d87
https://doi.org/10.1186/s12936-016-1535-8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání